Annual Cash & Cash Equivalents
$11.59B$1.87B-13.87%
Summary
- Current Value
- As of today, NVS annual cash & cash equivalents is $11.59B, down -13.87% on
- Historical Performance
- NVS annual cash & cash equivalents is down -38.77% over the past 3 years, up +0.23% over the past 5 years
- All-Time High Comparison
- NVS annual cash & cash equivalents is currently -59.09% below its historical high of $28.33B set on
- 3-Year Low Comparison
- NVS annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- NVS annual cash & cash equivalents is higher than 99.48% of companies in Healthcare sector
Cash and Cash Equivalents Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $11.59B | -13.9% | -38.8% | +0.2% | +42.2% | |
| Quarterly Cash & Cash Equivalents | $6.98B | -3.0% | -43.1% | +71.1% | -20.4% | |
| Price | $150.17 | +29.7% | +54.6% | +70.4% | +164.0% | |
| Annual Current Assets | $30.46B | +2.5% | -17.5% | +2.6% | +13.9% | |
| Annual Total Liabilities | $69.02B | +10.2% | +10.7% | -8.6% | +28.6% | |
| Annual Working Capital | $3.18B | +214.4% | -61.5% | +194.0% | +56.6% | |
| Annual Net Income | $14.04B | +17.6% | +131.6% | +73.9% | +42.0% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $18.93B | N/A | -38.8% |
| 5Y | $28.33B | -59.1% | |
| All | $28.33B | -59.1% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $11.59B | at low | |
| 5Y | $11.56B | N/A | +0.2% |
| All | $5.08B | +128.4% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of NVS?
As of today, NVS annual cash & cash equivalents is $11.59B
What is 1-year change in NVS annual cash & cash equivalents?
NVS annual cash & cash equivalents is down -13.87% year-over-year
What is 3-year change in NVS annual cash & cash equivalents?
NVS annual cash & cash equivalents is down -38.77% over the past 3 years
How far is NVS annual cash & cash equivalents from its all-time high?
NVS annual cash & cash equivalents is currently -59.09% below its historical high of $28.33B set on December 31, 2021
How does NVS annual cash & cash equivalents rank versus sector peers?
NVS annual cash & cash equivalents is higher than 99.48% of companies in Healthcare sector
When is NVS next annual earnings release?
As of today, the next annual earnings release for NVS has not been scheduled
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Quarterly Cash & Cash Equivalents
$6.98B$4.61B-39.80%
Summary
- Current Value
- As of today, NVS quarterly cash & cash equivalents is $6.98B, down -39.80% on
- Historical Performance
- NVS quarterly cash & cash equivalents is down -3.04% year-over-year, down -43.09% over the past 3 years
- All-Time High Comparison
- NVS quarterly cash & cash equivalents is currently -75.37% below its historical high of $28.33B set on
- 3-Year Low Comparison
- NVS quarterly cash & cash equivalents is at its 3-year low
- Sector Comparison
- NVS quarterly cash & cash equivalents is higher than 98.53% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $6.98B | -39.8% | -3.0% | -43.1% | +71.1% | |
| Annual Cash & Cash Equivalents | $11.59B | – | -13.9% | -38.8% | +0.2% | |
| Price | $150.17 | -10.9% | +29.7% | +54.6% | +70.4% | |
| Quarterly Current Assets | $26.61B | -12.7% | +6.0% | -17.1% | +19.9% | |
| Quarterly Total Liabilities | $79.61B | +15.3% | +29.5% | +32.5% | +11.9% | |
| Quarterly Working Capital | -$4.77B | -249.8% | +26.8% | -404.6% | +40.1% | |
| Quarterly Net Income | $3.17B | +31.8% | -12.2% | +47.0% | +53.9% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $11.59B | -39.8% | |
| 3Y | $14.43B | -51.6% | |
| 5Y | $28.33B | -75.4% | |
| All | $28.33B | -75.4% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $6.98B | at low | |
| 3Y | $6.98B | at low | |
| 5Y | $4.08B | N/A | +71.1% |
| All | $2.64B | +164.5% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of NVS?
As of today, NVS quarterly cash & cash equivalents is $6.98B
What is NVS quarterly cash & cash equivalents most recent change?
NVS quarterly cash & cash equivalents was down -39.80% on March 31, 2026
What is 1-year change in NVS quarterly cash & cash equivalents?
NVS quarterly cash & cash equivalents is down -3.04% year-over-year
How far is NVS quarterly cash & cash equivalents from its all-time high?
NVS quarterly cash & cash equivalents is currently -75.37% below its historical high of $28.33B set on December 31, 2021
How does NVS quarterly cash & cash equivalents rank versus sector peers?
NVS quarterly cash & cash equivalents is higher than 98.53% of companies in Healthcare sector
When is NVS next earnings release?
The next earnings release for NVS is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- NVS Official Website www.novartis.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm
- NVS Profile on Yahoo Finance finance.yahoo.com/quote/NVS
- NVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvs